This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medicis To Present At Cowen Healthcare Conference

SCOTTSDALE, Ariz., March 4, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 31 st Annual Cowen Healthcare Conference in Boston, Massachusetts. A live webcast of its presentation scheduled for Tuesday, March 8, 2011, at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time), may be accessed via the Internet.

The webcast will be available via a link on the Medicis corporate website at http://www.Medicis.com/company/index.asp . This link will allow visitors to the website to access the Medicis presentation. An archive of the webcast will be available on the Medicis corporate website for 10 business days following the live presentation. 

About Medicis

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. The Company is dedicated to helping patients attain a healthy and youthful appearance and self-image. Medicis has leading branded prescription products in a number of therapeutic and aesthetic categories. The Company's products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance.

The Company's products include the brands DYSPORT ® (abobotulinumtoxinA) 300 Units for Injection, PERLANE ® Injectable Gel, PERLANE-L ® Injectable Gel with 0.3% Lidocaine, RESTYLANE ® Injectable Gel, RESTYLANE-L ® Injectable Gel with 0.3% Lidocaine, DYNACIN ® (minocycline HCl Tablets, USP), LOPROX ® (ciclopirox) Gel 0.77% and Shampoo 1%, SOLODYN ® (minocycline HCl, USP) Extended Release Tablets, VANOS ® (fluocinonide) Cream 0.1%, ZIANA ® (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, AMMONUL ® (sodium phenylacetate and sodium benzoate) Injection 10%/10%, BUPHENYL ® (sodium phenylbutyrate) Tablets and Powder, the LIPOSONIX™ system 1 and the over-the-counter brand ESOTERICA ®.

For more information about Medicis, please visit the Company's website at www.Medicis.com . Printed copies of the Company's complete audited financial statements are available free of charge upon request.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. All statements included in this press release that address activities, events or developments that Medicis expects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made by Medicis based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. No assurances can be given, however, that these activities, events or developments will occur or that such results will be achieved. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Medicis. Several of these risks are outlined in the Company's most recent annual report on Form 10-K for the year ended December 31, 2010, and other documents we file with the Securities and Exchange Commission. Forward-looking statements represent the judgment of Medicis management as of the date of this release, and Medicis disclaims any intent or obligation to update any forward-looking statements contained herein, which speak as of the date hereof.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs